MORPHINE SULFATE

MORPHINE SULFATE was reported 121416 times

MORPHINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 144 0.4752
1 LEARNING DISABILITY 1173 0.2201
2 SEDATION COMPLICATION 531 0.2079
3 DRUG DEPENDENCE 32899 0.2044
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 132 0.1976
5 NEUROLOGIC NEGLECT SYNDROME 107 0.1924
6 LUPUS VULGARIS 239 0.1897
7 VISION ABNORMAL NEONATAL 79 0.1890
8 RETINITIS 316 0.1828
9 DRUG WITHDRAWAL SYNDROME NEONATAL 2606 0.1758
10 SUBSTANCE DEPENDENCE 113 0.1679
11 POLYSUBSTANCE ABUSE 106 0.1669
12 MULTIPLE DRUG OVERDOSE ACCIDENTAL 74 0.1619
13 DRUG WITHDRAWAL SYNDROME 13759 0.1566
14 EMOTIONAL DISTRESS 16962 0.1400
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 120 0.1294
16 SERONEGATIVE ARTHRITIS 147 0.1283
17 CAROTID ARTERY THROMBOSIS 108 0.1272
18 DEVELOPMENTAL DELAY 1141 0.1264
19 CREATININE RENAL CLEARANCE DECREASED 502 0.1253
20 SELF ESTEEM DECREASED 303 0.1251
21 TEMPERATURE REGULATION DISORDER 262 0.1175
22 ACUTE CHEST SYNDROME 98 0.1115
23 OVERDOSE 23557 0.1091
24 MULTIPLE DRUG THERAPY 78 0.1034
25 FEMALE GENITAL TRACT FISTULA 169 0.0989
26 DEPENDENCE 5010 0.0913
27 DRUG TOLERANCE INCREASED 71 0.0909
28 SUBSTANCE ABUSE 739 0.0907
29 GRANULOMA SKIN 72 0.0877
30 BONE EROSION 292 0.0825
31 ADJUSTMENT DISORDER 105 0.0808
32 DRUG DIVERSION 491 0.0794
33 LEARNING DISORDER 189 0.0783
34 TOXICOLOGIC TEST ABNORMAL 47 0.0776
35 CREATININE RENAL CLEARANCE INCREASED 58 0.0775
36 SUBSTANCE USE DISORDER 246 0.0771
37 MULTIPLE DRUG OVERDOSE 377 0.0759
38 RADICULOPATHY 191 0.0724
39 RHEUMATOID FACTOR POSITIVE 409 0.0707
40 TOXICITY TO VARIOUS AGENTS 11855 0.0702
41 DEEP VEIN THROMBOSIS POSTOPERATIVE 133 0.0664
42 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 137 0.0661
43 DISLOCATION OF VERTEBRA 148 0.0648
44 MACULAR DEGENERATION 763 0.0638
45 SPINA BIFIDA 133 0.0638
46 SWOLLEN JOINT COUNT INCREASED 202 0.0633
47 SPEECH DISORDER DEVELOPMENTAL 180 0.0627
48 CONTRAST MEDIA ALLERGY 111 0.0606
49 DRUG TOLERANCE 300 0.0592
50 TOTAL LUNG CAPACITY DECREASED 93 0.0582
51 PROCTITIS 154 0.0549
52 RHEUMATIC FEVER 245 0.0549
53 POST-TRAUMATIC STRESS DISORDER 367 0.0547
54 PERSONALITY DISORDER 140 0.0534
55 CHRONIC SINUSITIS 198 0.0527
56 BLOOD CALCIUM DECREASED 593 0.0527
57 FOETAL DEATH 265 0.0510
58 MASTOIDITIS 50 0.0510
59 IMPRISONMENT 90 0.0509
60 RESPIRATORY RATE DECREASED 157 0.0499
61 SOFT TISSUE DISORDER 55 0.0496
62 BLOOD PARATHYROID HORMONE DECREASED 73 0.0492
63 RESPIRATORY DEPRESSION 601 0.0490
64 DISABILITY 941 0.0475
65 MULTIPLE CONGENITAL ABNORMALITIES 68 0.0472
66 BRADYPNOEA 127 0.0470
67 PLEURITIC PAIN 129 0.0467
68 DRUG ABUSE 3835 0.0460
69 MIOSIS 364 0.0453
70 ALLODYNIA 51 0.0436
71 DRUG TOLERANCE DECREASED 120 0.0427
72 SEDATION 1117 0.0426
73 ATTENTION DEFICIT HYPERACTIVITY DISORDER 179 0.0425
74 EXOSTOSIS 371 0.0406
75 JOINT DISLOCATION 425 0.0402
76 COMPLEX REGIONAL PAIN SYNDROME 59 0.0399
77 FOOD ALLERGY 307 0.0397
78 OBLITERATIVE BRONCHIOLITIS 51 0.0388
79 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 278 0.0388
80 DRUG ABUSER 237 0.0385
81 JUDGEMENT IMPAIRED 55 0.0378
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 406 0.0367
83 OSTEOLYSIS 73 0.0357
84 PAIN 21751 0.0354
85 LUNG OPACITY 93 0.0353
86 ACCIDENTAL OVERDOSE 1279 0.0349
87 ORTHOSTATIC HYPOTENSION 602 0.0345
88 BREATH SOUNDS ABNORMAL 168 0.0340
89 CANCER PAIN 87 0.0340
90 PANNICULITIS 82 0.0339
91 HYPERCHOLESTEROLAEMIA 325 0.0336
92 LUPUS-LIKE SYNDROME 298 0.0328
93 FOOT DEFORMITY 360 0.0324
94 INADEQUATE ANALGESIA 271 0.0319
95 DUODENAL ULCER PERFORATION 234 0.0314
96 HELICOBACTER INFECTION 323 0.0314
97 PEMPHIGUS 392 0.0313
98 EXPOSURE TO TOXIC AGENT 100 0.0312
99 SYNOVITIS 549 0.0304
100 INTENTIONAL MISUSE 58 0.0304
101 WITHDRAWAL SYNDROME 1257 0.0299
102 DRUG SCREEN POSITIVE 227 0.0287
103 HYPERAESTHESIA 232 0.0282
104 HOMICIDE 52 0.0282
105 GANGRENE 170 0.0282
106 GENERAL PHYSICAL CONDITION ABNORMAL 190 0.0280
107 ACCIDENTAL DEATH 52 0.0280
108 RHEUMATOID NODULE 77 0.0279
109 HAND DEFORMITY 365 0.0278
110 CONGENITAL ANOMALY 215 0.0277
111 PRESCRIBED OVERDOSE 531 0.0274
112 MENTAL DISORDER 1189 0.0273
113 BURSITIS 327 0.0269
114 PSYCHOMOTOR SKILLS IMPAIRED 70 0.0267
115 HEPATITIS C 321 0.0266
116 DEPRESSED LEVEL OF CONSCIOUSNESS 1048 0.0265
117 WOUND INFECTION 285 0.0260
118 SPINAL FUSION SURGERY 104 0.0256
119 HYPERPHOSPHATAEMIA 55 0.0256
120 PUPILLARY REFLEX IMPAIRED 47 0.0254
121 PERICARDITIS 415 0.0247
122 NEUTROPENIC SEPSIS 175 0.0245
123 GUN SHOT WOUND 46 0.0242
124 BREAKTHROUGH PAIN 56 0.0242
125 WALKING AID USER 159 0.0241
126 DRUG USE DISORDER 198 0.0235
127 IMMUNODEFICIENCY 346 0.0232
128 RESPIRATORY ACIDOSIS 91 0.0231
129 BRAIN INJURY 230 0.0229
130 ASPIRATION 251 0.0229
131 CONTRAINDICATED PRODUCT ADMINISTERED 689 0.0227
132 HYPERCAPNIA 68 0.0226
133 COELIAC DISEASE 221 0.0225
134 MUSCLE INJURY 186 0.0224
135 FACET JOINT SYNDROME 73 0.0224
136 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
137 FOETAL EXPOSURE DURING PREGNANCY 1797 0.0221
138 ALCOHOL ABUSE 59 0.0220
139 ILL-DEFINED DISORDER 1339 0.0220
140 WHITE BLOOD CELL COUNT ABNORMAL 140 0.0219
141 SENSORY LOSS 175 0.0217
142 METASTASES TO SPINE 72 0.0214
143 RALES 124 0.0213
144 PULMONARY FIBROSIS 409 0.0213
145 ORAL CANDIDIASIS 279 0.0212
146 SPONDYLITIS 77 0.0212
147 HEPATIC CIRRHOSIS 395 0.0210
148 ARTERIAL OCCLUSIVE DISEASE 164 0.0208
149 TOOTH LOSS 432 0.0208
150 FIBROMYALGIA 505 0.0208
151 DEATH 17488 0.0203
152 ROAD TRAFFIC ACCIDENT 846 0.0202
153 INTERVERTEBRAL DISC DEGENERATION 186 0.0201
154 RESPIRATORY ARREST 553 0.0200
155 BONE LESION 72 0.0199
156 HYPOVENTILATION 65 0.0199
157 PNEUMONIA VIRAL 63 0.0197
158 JOINT RANGE OF MOTION DECREASED 263 0.0196
159 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 51 0.0195
160 WOUND 544 0.0194
161 UPPER RESPIRATORY TRACT INFECTION 895 0.0194
162 PATHOLOGICAL FRACTURE 98 0.0193
163 SCIATICA 306 0.0192
164 MYOCLONUS 228 0.0191
165 INFUSION RELATED REACTION 1263 0.0190
166 GRIP STRENGTH DECREASED 167 0.0190
167 APNOEA 147 0.0189
168 LIVER INJURY 463 0.0188
169 BRONCHITIS CHRONIC 46 0.0188
170 EUPHORIC MOOD 191 0.0186
171 NEAR DEATH EXPERIENCE 61 0.0185
172 HYPOPNOEA 64 0.0184
173 COGNITIVE DISORDER 854 0.0183
174 MAJOR DEPRESSION 131 0.0179
175 OTITIS MEDIA 59 0.0178
176 IMPAIRED WORK ABILITY 378 0.0177
177 BLOOD PRESSURE DIASTOLIC DECREASED 130 0.0176
178 METABOLIC ENCEPHALOPATHY 52 0.0173
179 BEHAVIOUR DISORDER 93 0.0172
180 GLOSSODYNIA 384 0.0171
181 INJURY 1198 0.0170
182 SPUTUM DISCOLOURED 160 0.0169
183 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 109 0.0168
184 BRONCHIECTASIS 113 0.0168
185 LUMBAR SPINAL STENOSIS 49 0.0168
186 COMA 797 0.0167
187 IMPAIRED DRIVING ABILITY 189 0.0166
188 SKIN NECROSIS 86 0.0166
189 ANXIETY DISORDER 55 0.0164
190 DRUG INTOLERANCE 1586 0.0164
191 PERIPHERAL VENOUS DISEASE 67 0.0164
192 JOINT STIFFNESS 430 0.0164
193 BLOOD CALCIUM INCREASED 143 0.0163
194 BREAST CANCER STAGE III 105 0.0162
195 VAGINAL DISCHARGE 164 0.0162
196 STUPOR 52 0.0162
197 MOBILITY DECREASED 1161 0.0161
198 PRESCRIBED UNDERDOSE 320 0.0160
199 MOTOR DYSFUNCTION 163 0.0160
200 SPINAL OSTEOARTHRITIS 140 0.0159
201 OSTEOARTHRITIS 675 0.0159
202 UNRESPONSIVE TO STIMULI 409 0.0158
203 FOLLICULITIS 166 0.0158
204 QUALITY OF LIFE DECREASED 212 0.0158
205 DELIRIUM 547 0.0157
206 RENAL FUNCTION TEST ABNORMAL 73 0.0157
207 SPINAL CORD COMPRESSION 61 0.0156
208 HEMIPLEGIA 130 0.0156
209 INCOHERENT 101 0.0156
210 AUTOIMMUNE DISORDER 152 0.0156
211 C-REACTIVE PROTEIN ABNORMAL 99 0.0154
212 PARAESTHESIA ORAL 220 0.0152
213 ATELECTASIS 145 0.0150
214 C-REACTIVE PROTEIN INCREASED 538 0.0148
215 MENTAL STATUS CHANGES 410 0.0147
216 HYPOXIA 518 0.0147
217 NIGHTMARE 509 0.0147
218 AFFECT LABILITY 141 0.0146
219 DENTAL CARIES 161 0.0145
220 TOOTH INJURY 63 0.0145
221 CONSTIPATION 3126 0.0143
222 IRRITABLE BOWEL SYNDROME 306 0.0143
223 BODY TEMPERATURE DECREASED 139 0.0141
224 HYPERCALCAEMIA 174 0.0141
225 TYPE 2 DIABETES MELLITUS 473 0.0140
226 MULTIPLE MYELOMA 65 0.0139
227 FUNCTIONAL GASTROINTESTINAL DISORDER 48 0.0139
228 MATERNAL EXPOSURE TIMING UNSPECIFIED 52 0.0138
229 AMNESIA 899 0.0138
230 IMPAIRED QUALITY OF LIFE 197 0.0137
231 EXPOSURE DURING PREGNANCY 850 0.0137
232 OBSTRUCTIVE AIRWAYS DISORDER 152 0.0137
233 ULCER 217 0.0136
234 DEPRESSION 3072 0.0135
235 LUNG INFILTRATION 119 0.0135
236 HIP ARTHROPLASTY 206 0.0134
237 HEPATIC ENZYME INCREASED 916 0.0134
238 EXPOSURE VIA BREAST MILK 53 0.0133
239 DRUG TOXICITY 181 0.0133
240 ENDOCARDITIS 68 0.0132
241 POISONING DELIBERATE 124 0.0131
242 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 66 0.0130
243 BLOOD PRESSURE DIASTOLIC INCREASED 60 0.0130
244 RHEUMATOID ARTHRITIS 1476 0.0130
245 ARTERIOSCLEROSIS CORONARY ARTERY 86 0.0130
246 PERSONALITY CHANGE 120 0.0129
247 LIVE BIRTH 108 0.0129
248 LIVER FUNCTION TEST INCREASED 277 0.0129
249 LEUKOENCEPHALOPATHY 48 0.0129
250 MUSCLE SPASTICITY 158 0.0128
251 COORDINATION ABNORMAL 179 0.0128
252 VASCULAR DEVICE INFECTION 58 0.0128
253 ILEUS PARALYTIC 57 0.0128
254 AFFECTIVE DISORDER 100 0.0127
255 UNEVALUABLE EVENT 962 0.0127
256 OSTEOPOROSIS 523 0.0127
257 LOWER LIMB FRACTURE 243 0.0126
258 PROCTALGIA 81 0.0126
259 FAECALOMA 69 0.0126
260 EAR INFECTION 334 0.0125
261 FAILURE TO THRIVE 65 0.0125
262 BRAIN OEDEMA 158 0.0125
263 BACK INJURY 136 0.0125
264 NERVE INJURY 139 0.0125
265 MATERNAL EXPOSURE DURING PREGNANCY 1105 0.0124
266 GENERAL PHYSICAL HEALTH DETERIORATION 1430 0.0123
267 SPINAL STENOSIS 51 0.0123
268 BLOOD TEST ABNORMAL 173 0.0123
269 ANXIETY 3493 0.0123
270 SYSTEMIC LUPUS ERYTHEMATOSUS 435 0.0122
271 ALCOHOLISM 52 0.0121
272 PULMONARY CONGESTION 159 0.0120
273 ACCIDENTAL EXPOSURE 50 0.0120
274 HYDRONEPHROSIS 89 0.0119
275 METASTASES TO BONE 195 0.0119
276 HYPERHIDROSIS 1527 0.0118
277 PNEUMONIA ASPIRATION 296 0.0118
278 MENTAL IMPAIRMENT 286 0.0118
279 INTENTIONAL PRODUCT MISUSE 1032 0.0118
280 ARTHRITIS 927 0.0118
281 SOCIAL AVOIDANT BEHAVIOUR 68 0.0117
282 BLOOD PRESSURE SYSTOLIC INCREASED 228 0.0117
283 ASPHYXIA 95 0.0116
284 PULMONARY MASS 173 0.0116
285 HEMIPARESIS 196 0.0116
286 LYMPHOEDEMA 80 0.0116
287 SMALL INTESTINAL OBSTRUCTION 142 0.0115
288 PROTHROMBIN TIME PROLONGED 69 0.0115
289 SUSPECTED SUICIDE 54 0.0115
290 HYPOPHOSPHATAEMIA 85 0.0115
291 JOINT SWELLING 1388 0.0115
292 CONFUSIONAL STATE 1856 0.0115
293 NEPHROLITHIASIS 526 0.0115
294 EATING DISORDER 244 0.0114
295 AUTISM SPECTRUM DISORDER 63 0.0114
296 SLEEP APNOEA SYNDROME 218 0.0114
297 COMPRESSION FRACTURE 61 0.0114
298 ARTERIOSCLEROSIS 107 0.0114
299 SINUS TACHYCARDIA 161 0.0113
300 PHYSICAL DISABILITY 50 0.0113
301 OSTEOMYELITIS 204 0.0113
302 NEPHROGENIC ANAEMIA 52 0.0112
303 RENAL CYST 89 0.0112
304 MUSCULOSKELETAL STIFFNESS 977 0.0111
305 DECUBITUS ULCER 90 0.0110
306 DECREASED INTEREST 65 0.0110
307 PURULENT DISCHARGE 47 0.0110
308 SWOLLEN TONGUE 343 0.0110
309 TENDERNESS 114 0.0109
310 IMPAIRED HEALING 359 0.0109
311 RESPIRATORY RATE INCREASED 97 0.0109
312 ACCIDENT 130 0.0109
313 HEPATIC LESION 47 0.0109
314 DYSARTHRIA 409 0.0109
315 CARDIAC DISORDER 1010 0.0108
316 TROPONIN INCREASED 82 0.0108
317 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
318 SINUS CONGESTION 145 0.0107
319 BALANCE DISORDER 925 0.0107
320 NEURALGIA 260 0.0107
321 CARDIOMEGALY 131 0.0106
322 KNEE ARTHROPLASTY 224 0.0106
323 PRODUCT PRESCRIBING ISSUE 231 0.0106
324 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 508 0.0106
325 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 181 0.0105
326 PARANOIA 182 0.0105
327 SPINAL OPERATION 130 0.0105
328 SICKLE CELL ANAEMIA WITH CRISIS 166 0.0105
329 ACUTE RESPIRATORY FAILURE 202 0.0105
330 LOWER RESPIRATORY TRACT INFECTION 477 0.0105
331 HEPATIC CYTOLYSIS 133 0.0104
332 CEREBRAL DISORDER 77 0.0104
333 PHLEBITIS 53 0.0103
334 BLOOD ALBUMIN DECREASED 82 0.0103
335 PULSE ABSENT 49 0.0103
336 BENIGN PROSTATIC HYPERPLASIA 53 0.0103
337 FLANK PAIN 96 0.0102
338 THERAPEUTIC PRODUCT EFFECT DECREASED 458 0.0102
339 LETHARGY 588 0.0102
340 ACIDOSIS 78 0.0102
341 DISTURBANCE IN ATTENTION 550 0.0102
342 RENAL FAILURE ACUTE 431 0.0101
343 BLOOD PRESSURE SYSTOLIC DECREASED 46 0.0101
344 HALLUCINATION 757 0.0100
345 HYPERLIPIDAEMIA 119 0.0099
346 BODY TEMPERATURE INCREASED 203 0.0099
347 BLOOD TESTOSTERONE DECREASED 68 0.0099
348 GAIT INABILITY 332 0.0099
349 SOMNOLENCE 1993 0.0099
350 POISONING 124 0.0099
351 BIPOLAR DISORDER 106 0.0097
352 BEDRIDDEN 128 0.0097
353 OEDEMA PERIPHERAL 1173 0.0096
354 CONCUSSION 74 0.0095
355 OXYGEN SATURATION DECREASED 536 0.0095
356 TREATMENT FAILURE 789 0.0095
357 PSORIATIC ARTHROPATHY 385 0.0095
358 PROCEDURAL PAIN 263 0.0095
359 MUSCULOSKELETAL CHEST PAIN 146 0.0094
360 SUICIDE ATTEMPT 569 0.0094
361 CYANOSIS 147 0.0093
362 GASTROINTESTINAL MOTILITY DISORDER 50 0.0093
363 DYSPHAGIA 885 0.0093
364 ARTHROPATHY 518 0.0093
365 SPINAL COMPRESSION FRACTURE 77 0.0093
366 THERMAL BURN 66 0.0093
367 SEXUAL DYSFUNCTION 109 0.0093
368 MALNUTRITION 104 0.0093
369 DECREASED IMMUNE RESPONSIVENESS 91 0.0093
370 URINARY RETENTION 307 0.0092
371 PULMONARY OEDEMA 412 0.0092
372 RESPIRATORY TRACT CONGESTION 146 0.0092
373 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 653 0.0092
374 BLOOD PRESSURE FLUCTUATION 220 0.0092
375 CACHEXIA 47 0.0091
376 RECTAL HAEMORRHAGE 392 0.0091
377 RIB FRACTURE 187 0.0091
378 METASTASES TO LUNG 105 0.0091
379 GINGIVITIS 49 0.0091
380 CARDIO-RESPIRATORY ARREST 379 0.0091
381 HYPOVOLAEMIA 53 0.0090
382 AGGRESSION 453 0.0090
383 BLOOD CHOLESTEROL INCREASED 421 0.0090
384 RESPIRATORY DISTRESS 249 0.0090
385 SINUS DISORDER 178 0.0090
386 HYPOTENSION 1801 0.0090
387 PLEURAL EFFUSION 546 0.0090
388 DISCOMFORT 543 0.0089
389 BONE DISORDER 162 0.0089
390 SCOLIOSIS 55 0.0089
391 HAEMATOCRIT DECREASED 176 0.0089
392 SKIN ULCER 229 0.0088
393 THINKING ABNORMAL 165 0.0088
394 ASTHMA 1000 0.0088
395 TOOTH FRACTURE 97 0.0088
396 CELLULITIS 442 0.0088
397 ENCEPHALOPATHY 215 0.0087
398 FLUID RETENTION 445 0.0087
399 HAEMOPTYSIS 244 0.0087
400 INTERVERTEBRAL DISC PROTRUSION 191 0.0087
401 EMPHYSEMA 88 0.0087
402 SKIN HAEMORRHAGE 129 0.0087
403 WHEEZING 513 0.0086
404 LARGE INTESTINE PERFORATION 60 0.0086
405 VOMITING 4061 0.0086
406 CARDIAC ARREST 711 0.0086
407 NEUTROPHIL COUNT INCREASED 88 0.0086
408 RENAL FAILURE CHRONIC 66 0.0086
409 ORAL PAIN 191 0.0085
410 PRE-EXISTING CONDITION IMPROVED 53 0.0085
411 ANGINA PECTORIS 243 0.0085
412 HYPOMAGNESAEMIA 118 0.0085
413 HYPOKALAEMIA 390 0.0084
414 SLEEP DISORDER 596 0.0084
415 DIVERTICULUM 60 0.0084
416 INFECTION 1218 0.0084
417 HOSPICE CARE 83 0.0084
418 FREQUENT BOWEL MOVEMENTS 226 0.0084
419 SUICIDAL IDEATION 765 0.0083
420 OEDEMA 453 0.0083
421 SPINAL DISORDER 79 0.0083
422 COMPLETED SUICIDE 694 0.0083
423 MUCOSAL INFLAMMATION 218 0.0083
424 METASTASES TO CENTRAL NERVOUS SYSTEM 107 0.0083
425 BLOOD ALKALINE PHOSPHATASE INCREASED 205 0.0082
426 HAEMORRHOIDS 161 0.0082
427 DISORIENTATION 327 0.0082
428 TOOTH ABSCESS 84 0.0082
429 STOMATITIS 500 0.0082
430 ANGIOEDEMA 364 0.0082
431 PSYCHOLOGICAL TRAUMA 71 0.0082
432 ANOREXIA 106 0.0082
433 GASTROINTESTINAL DISORDER 731 0.0082
434 RENAL TUBULAR NECROSIS 80 0.0081
435 BACK PAIN 1892 0.0081
436 BLOOD MAGNESIUM DECREASED 70 0.0081
437 HYPOTHERMIA 82 0.0081
438 OBESITY 129 0.0081
439 TOOTH DISORDER 180 0.0081
440 SKIN LACERATION 88 0.0081
441 BLISTER 453 0.0081
442 RESPIRATORY FAILURE 588 0.0081
443 AGITATION 592 0.0081
444 ILEUS 100 0.0080
445 COLITIS 305 0.0080
446 GASTROOESOPHAGEAL REFLUX DISEASE 647 0.0080
447 HALLUCINATION, VISUAL 169 0.0080
448 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 49 0.0079
449 LIP DRY 72 0.0079
450 FOOT FRACTURE 150 0.0079
451 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 411 0.0079
452 CANDIDA INFECTION 133 0.0079
453 MULTIPLE INJURIES 49 0.0078
454 APHASIA 235 0.0078
455 OESOPHAGITIS 85 0.0078
456 SOMNAMBULISM 51 0.0078
457 PNEUMONIA 2500 0.0077
458 ABDOMINAL PAIN 1784 0.0077
459 HYPERSENSITIVITY 1422 0.0077
460 MALIGNANT NEOPLASM PROGRESSION 784 0.0076
461 GROIN PAIN 67 0.0076
462 METASTASES TO LIVER 134 0.0076
463 ABNORMAL BEHAVIOUR 302 0.0076
464 HYPERTENSION 1610 0.0076
465 TRANSAMINASES INCREASED 169 0.0076
466 LEUKOCYTOSIS 137 0.0076
467 CYSTITIS 241 0.0076
468 THROMBOCYTOPENIA 846 0.0076
469 DYSPEPSIA 742 0.0075
470 ESCHERICHIA INFECTION 62 0.0075
471 TACHYCARDIA 669 0.0075
472 SWELLING 703 0.0075
473 MOOD SWINGS 238 0.0075
474 DECREASED APPETITE 1730 0.0074
475 NEUROTOXICITY 130 0.0074
476 SEPSIS 827 0.0074
477 ELECTROLYTE IMBALANCE 86 0.0074
478 OSTEOPENIA 112 0.0074
479 INCONTINENCE 78 0.0074
480 PREMATURE BABY 222 0.0074
481 HEART RATE DECREASED 258 0.0073
482 PARALYSIS 105 0.0073
483 DEHYDRATION 978 0.0073
484 BACK DISORDER 119 0.0073
485 PHARMACEUTICAL PRODUCT COMPLAINT 190 0.0073
486 HALLUCINATION, AUDITORY 116 0.0073
487 ECCHYMOSIS 50 0.0073
488 BLOOD POTASSIUM DECREASED 219 0.0073
489 DYSPHONIA 425 0.0073
490 SWELLING FACE 473 0.0073
491 NAUSEA 5746 0.0073
492 ORAL DISORDER 53 0.0072
493 DRUG INTERACTION 1146 0.0072
494 REFUSAL OF TREATMENT BY PATIENT 47 0.0072
495 LUNG DISORDER 352 0.0072
496 BRONCHITIS 530 0.0072
497 NERVE COMPRESSION 66 0.0071
498 PSEUDOMONAS INFECTION 61 0.0071
499 METASTASES TO LYMPH NODES 48 0.0071
500 ANGER 240 0.0071
501 DELUSION 110 0.0071
502 SEROTONIN SYNDROME 136 0.0071
503 ALTERED STATE OF CONSCIOUSNESS 153 0.0071
504 MUSCULOSKELETAL PAIN 369 0.0070
505 DYSURIA 259 0.0070
506 SINUSITIS 721 0.0070
507 HIATUS HERNIA 91 0.0070
508 HAEMATEMESIS 178 0.0070
509 HEPATOMEGALY 69 0.0070
510 HYPERSOMNIA 201 0.0070
511 LOSS OF CONSCIOUSNESS 898 0.0070
512 MICTURITION URGENCY 80 0.0070
513 FEEDING DISORDER 142 0.0070
514 PYREXIA 2420 0.0070
515 FALL 2323 0.0070
516 CLOSTRIDIUM DIFFICILE COLITIS 74 0.0070
517 POST PROCEDURAL COMPLICATION 134 0.0070
518 ASCITES 205 0.0070
519 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 54 0.0069
520 BASAL CELL CARCINOMA 108 0.0069
521 ADRENAL INSUFFICIENCY 84 0.0069
522 COLD SWEAT 122 0.0069
523 NERVOUS SYSTEM DISORDER 216 0.0069
524 OSTEONECROSIS OF JAW 171 0.0069
525 RASH ERYTHEMATOUS 330 0.0069
526 LIGAMENT SPRAIN 68 0.0069
527 PNEUMOTHORAX 109 0.0069
528 WEIGHT DECREASED 1918 0.0069
529 MUSCULAR WEAKNESS 780 0.0069
530 NECK PAIN 383 0.0068
531 ANKLE FRACTURE 106 0.0068
532 SNEEZING 153 0.0068
533 COLITIS ISCHAEMIC 46 0.0068
534 ANAEMIA 1300 0.0068
535 ACUTE RESPIRATORY DISTRESS SYNDROME 120 0.0068
536 ANAL INCONTINENCE 61 0.0068
537 PULMONARY HAEMORRHAGE 53 0.0068
538 LIVER FUNCTION TEST ABNORMAL 197 0.0068
539 NEOPLASM PROGRESSION 235 0.0068
540 DRUG-INDUCED LIVER INJURY 212 0.0068
541 HYPOAESTHESIA 1008 0.0067
542 ECONOMIC PROBLEM 102 0.0067
543 CHOLESTASIS 129 0.0067
544 BLOOD SODIUM DECREASED 126 0.0067
545 RETCHING 142 0.0067
546 ANAPHYLACTIC REACTION 367 0.0066
547 SPINAL FRACTURE 133 0.0066
548 MEDICATION ERROR 367 0.0066
549 PSYCHOTIC DISORDER 195 0.0066
550 DRUG ERUPTION 117 0.0066
551 VISUAL IMPAIRMENT 818 0.0066
552 JOINT INJURY 141 0.0066
553 TOOTH INFECTION 87 0.0066
554 PSORIASIS 861 0.0066
555 MASS 92 0.0066
556 END STAGE RENAL DISEASE 120 0.0066
557 HYPONATRAEMIA 370 0.0066
558 BLADDER DISORDER 65 0.0065
559 ABSCESS 104 0.0065
560 PLASMA CELL MYELOMA 254 0.0065
561 LYMPHOCYTE COUNT DECREASED 115 0.0065
562 RESTLESSNESS 238 0.0065
563 MYOCARDIAL ISCHAEMIA 74 0.0065
564 MOUTH ULCERATION 137 0.0065
565 BACTERAEMIA 77 0.0065
566 POOR VENOUS ACCESS 67 0.0065
567 HICCUPS 53 0.0065
568 EJECTION FRACTION DECREASED 100 0.0064
569 EAR PAIN 125 0.0064
570 URINE OUTPUT DECREASED 56 0.0064
571 BLOOD POTASSIUM INCREASED 104 0.0064
572 BOWEL MOVEMENT IRREGULARITY 49 0.0064
573 NIGHT SWEATS 206 0.0064
574 MYDRIASIS 82 0.0064
575 HERPES ZOSTER 367 0.0064
576 PSYCHIATRIC SYMPTOM 47 0.0064
577 WHITE BLOOD CELL COUNT INCREASED 244 0.0064
578 HYPOCALCAEMIA 120 0.0063
579 SCHIZOPHRENIA 77 0.0063
580 INFLAMMATION 327 0.0063
581 MEMORY IMPAIRMENT 868 0.0063
582 DEEP VEIN THROMBOSIS 409 0.0063
583 DISEASE PROGRESSION 743 0.0063
584 BLOOD CREATININE INCREASED 409 0.0063
585 ABDOMINAL DISCOMFORT 1050 0.0063
586 CHEST PAIN 1159 0.0063
587 STAPHYLOCOCCAL INFECTION 206 0.0062
588 FULL BLOOD COUNT ABNORMAL 66 0.0062
589 SKIN INFECTION 70 0.0062
590 PYELONEPHRITIS 54 0.0062
591 ILLNESS 641 0.0062
592 BACTERIAL INFECTION 116 0.0062
593 PAIN IN JAW 176 0.0062
594 ROTATOR CUFF SYNDROME 79 0.0061
595 GENERALISED OEDEMA 76 0.0061
596 LEUKOPENIA 307 0.0061
597 INTESTINAL OBSTRUCTION 230 0.0061
598 MITRAL VALVE INCOMPETENCE 69 0.0061
599 ALANINE AMINOTRANSFERASE INCREASED 374 0.0061
600 RESPIRATORY DISORDER 182 0.0061
601 PANIC ATTACK 221 0.0061
602 INSOMNIA 1615 0.0061
603 PULMONARY EMBOLISM 575 0.0060
604 BRADYCARDIA 320 0.0060
605 MULTI-ORGAN FAILURE 104 0.0060
606 IMPAIRED GASTRIC EMPTYING 82 0.0060
607 ASPARTATE AMINOTRANSFERASE INCREASED 319 0.0060
608 LIVER DISORDER 264 0.0059
609 CONTUSION 572 0.0059
610 URINARY INCONTINENCE 176 0.0059
611 GALLBLADDER DISORDER 106 0.0059
612 HEPATIC FAILURE 179 0.0059
613 BONE PAIN 346 0.0059
614 HYPERKALAEMIA 207 0.0059
615 ANHEDONIA 155 0.0059
616 GAIT DISTURBANCE 1124 0.0059
617 TOOTH EXTRACTION 73 0.0059
618 SUDDEN DEATH 62 0.0059
619 TOOTHACHE 106 0.0058
620 UROSEPSIS 54 0.0058
621 PANCREATITIS ACUTE 131 0.0058
622 CORONARY ARTERY DISEASE 176 0.0058
623 INTESTINAL PERFORATION 65 0.0058
624 PRODUCTIVE COUGH 276 0.0058
625 CARDIAC MURMUR 50 0.0058
626 RESTLESS LEGS SYNDROME 105 0.0058
627 CIRCULATORY COLLAPSE 98 0.0057
628 RENAL FAILURE 764 0.0057
629 INTERNATIONAL NORMALISED RATIO INCREASED 164 0.0057
630 LIMB INJURY 156 0.0057
631 GASTRIC DISORDER 197 0.0057
632 BLOOD UREA INCREASED 96 0.0057
633 PHARYNGITIS 71 0.0057
634 SPLENOMEGALY 67 0.0057
635 ACUTE KIDNEY INJURY 875 0.0057
636 HEPATIC STEATOSIS 106 0.0057
637 MUSCLE TWITCHING 131 0.0057
638 FEBRILE NEUTROPENIA 377 0.0057
639 BREAST CANCER METASTATIC 61 0.0057
640 NEUROPATHY PERIPHERAL 539 0.0057
641 TOXIC EPIDERMAL NECROLYSIS 86 0.0057
642 INTENTIONAL PRODUCT USE ISSUE 494 0.0056
643 ORAL HERPES 110 0.0056
644 PERIPHERAL SWELLING 866 0.0056
645 PULMONARY HYPERTENSION 117 0.0056
646 RHINORRHOEA 363 0.0056
647 DRY MOUTH 455 0.0056
648 BLOOD PRESSURE DECREASED 371 0.0056
649 URTICARIA 935 0.0056
650 HEADACHE 3483 0.0055
651 HAEMOGLOBIN DECREASED 570 0.0055
652 MUSCLE STRAIN 48 0.0055
653 SPINAL PAIN 65 0.0055
654 IRON DEFICIENCY ANAEMIA 51 0.0055
655 TREMOR 914 0.0055
656 INTENTIONAL DRUG MISUSE 115 0.0055
657 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 301 0.0055
658 HAEMATOCHEZIA 302 0.0055
659 TUMOUR LYSIS SYNDROME 48 0.0055
660 KIDNEY INFECTION 107 0.0054
661 HEPATITIS 139 0.0054
662 ASTHENIA 2038 0.0054
663 PRODUCT USE ISSUE 1018 0.0054
664 COAGULOPATHY 90 0.0054
665 CYTOKINE RELEASE SYNDROME 108 0.0054
666 SEPTIC SHOCK 234 0.0054
667 FACIAL PAIN 48 0.0054
668 COLITIS ULCERATIVE 240 0.0054
669 HYPOPHAGIA 137 0.0054
670 VITAMIN D DEFICIENCY 52 0.0053
671 LYMPHADENOPATHY 188 0.0053
672 CHOLELITHIASIS 174 0.0053
673 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 90 0.0053
674 PELVIC PAIN 96 0.0053
675 NASOPHARYNGITIS 973 0.0053
676 RHABDOMYOLYSIS 220 0.0053
677 HEPATIC ENCEPHALOPATHY 49 0.0052
678 DEAFNESS 137 0.0052
679 BLOOD LACTATE DEHYDROGENASE INCREASED 83 0.0052
680 FATIGUE 4064 0.0052
681 SHOCK 120 0.0052
682 PNEUMONITIS 142 0.0052
683 FULL BLOOD COUNT DECREASED 105 0.0052
684 PAIN IN EXTREMITY 1534 0.0052
685 CATARACT 310 0.0052
686 DEVICE RELATED INFECTION 80 0.0052
687 DRUG LEVEL INCREASED 86 0.0052
688 NEUTROPHIL COUNT DECREASED 211 0.0052
689 GASTRITIS 136 0.0052
690 MIGRAINE 493 0.0052
691 VENTRICULAR TACHYCARDIA 85 0.0051
692 THERAPY PARTIAL RESPONDER 80 0.0051
693 RASH 2233 0.0051
694 SUPRAVENTRICULAR TACHYCARDIA 49 0.0051
695 MALAISE 2243 0.0051
696 PANCYTOPENIA 285 0.0051
697 BLOOD PRESSURE INCREASED 778 0.0051
698 KNEE OPERATION 50 0.0051
699 TACHYPNOEA 69 0.0051
700 GASTRIC ULCER 96 0.0050
701 SEIZURE 583 0.0050
702 LOCALISED INFECTION 122 0.0050
703 VENTRICULAR FIBRILLATION 56 0.0050
704 BLOOD BILIRUBIN INCREASED 136 0.0050
705 DYSPNOEA 2842 0.0050
706 SPEECH DISORDER 263 0.0050
707 SEASONAL ALLERGY 71 0.0050
708 GAMMA-GLUTAMYLTRANSFERASE INCREASED 110 0.0050
709 FEAR 133 0.0049
710 DIVERTICULITIS 137 0.0049
711 RENAL DISORDER 230 0.0049
712 DERMATITIS CONTACT 56 0.0049
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 141 0.0049
714 CRYING 178 0.0049
715 AGRANULOCYTOSIS 91 0.0049
716 GENERALISED TONIC-CLONIC SEIZURE 81 0.0049
717 PERITONITIS 101 0.0049
718 SINUS BRADYCARDIA 47 0.0049
719 ARTHRALGIA 2019 0.0049
720 CARPAL TUNNEL SYNDROME 68 0.0049
721 FEELING COLD 135 0.0048
722 PANCREATITIS 255 0.0048
723 HEART RATE IRREGULAR 109 0.0048
724 HYPOKINESIA 70 0.0048
725 SCAR 82 0.0048
726 NEOPLASM 55 0.0048
727 NO THERAPEUTIC RESPONSE 58 0.0048
728 CHOLECYSTECTOMY 54 0.0047
729 VENTRICULAR EXTRASYSTOLES 49 0.0047
730 CONDITION AGGRAVATED 1434 0.0047
731 MULTIPLE ORGAN DYSFUNCTION SYNDROME 133 0.0047
732 ABDOMINAL PAIN UPPER 965 0.0047
733 GOUT 84 0.0047
734 DYSKINESIA 190 0.0047
735 EMOTIONAL DISORDER 143 0.0046
736 PRODUCT USE IN UNAPPROVED INDICATION 1149 0.0046
737 TASTE DISORDER 94 0.0046
738 IMMUNE SYSTEM DISORDER 61 0.0046
739 UPPER LIMB FRACTURE 92 0.0046
740 URINARY TRACT INFECTION 787 0.0046
741 DIARRHOEA 2975 0.0046
742 THYROID DISORDER 71 0.0046
743 METABOLIC ACIDOSIS 147 0.0046
744 CHRONIC KIDNEY DISEASE 347 0.0046
745 FISTULA 51 0.0045
746 PLATELET COUNT INCREASED 59 0.0045
747 PALLOR 123 0.0045
748 ERYTHEMA 925 0.0045
749 MUSCLE ATROPHY 57 0.0045
750 HEART RATE INCREASED 445 0.0045
751 SURGERY 263 0.0045
752 PHARYNGEAL OEDEMA 69 0.0045
753 DISSEMINATED INTRAVASCULAR COAGULATION 63 0.0045
754 GASTROENTERITIS 65 0.0044
755 PLATELET COUNT DECREASED 474 0.0044
756 HIP FRACTURE 143 0.0044
757 CHEST DISCOMFORT 454 0.0044
758 PRURITUS 1703 0.0044
759 WEIGHT INCREASED 992 0.0044
760 ABDOMINAL DISTENSION 461 0.0044
761 FUNGAL INFECTION 147 0.0044
762 MUSCLE SPASMS 809 0.0044
763 DYSPNOEA EXERTIONAL 166 0.0044
764 CONVULSION 252 0.0044
765 CHILLS 516 0.0044
766 DEMENTIA 123 0.0044
767 CLOSTRIDIUM DIFFICILE INFECTION 96 0.0044
768 DYSSTASIA 128 0.0044
769 INFLUENZA 488 0.0044
770 DERMATITIS ALLERGIC 55 0.0044
771 RED BLOOD CELL COUNT DECREASED 125 0.0044
772 DEPRESSED MOOD 231 0.0044
773 CHOKING 85 0.0044
774 THROMBOSIS 349 0.0043
775 SKIN REACTION 61 0.0043
776 HEAD INJURY 137 0.0043
777 ERECTILE DYSFUNCTION 111 0.0043
778 ADVERSE DRUG REACTION 386 0.0043
779 ATAXIA 51 0.0043
780 ACTIVITIES OF DAILY LIVING IMPAIRED 85 0.0043
781 CHOLECYSTITIS 51 0.0043
782 CARDIOMYOPATHY 63 0.0043
783 IRRITABILITY 256 0.0043
784 HERNIA 82 0.0042
785 THERAPEUTIC RESPONSE DECREASED 257 0.0042
786 PERIPHERAL COLDNESS 58 0.0042
787 PALPITATIONS 490 0.0042
788 HYPOACUSIS 180 0.0042
789 POOR QUALITY SLEEP 90 0.0042
790 RENAL INJURY 124 0.0042
791 SARS-COV-2 TEST POSITIVE 55 0.0042
792 NEUTROPENIA 566 0.0042
793 HYPERGLYCAEMIA 151 0.0041
794 THERAPY NON-RESPONDER 186 0.0041
795 PROSTATIC SPECIFIC ANTIGEN INCREASED 57 0.0041
796 NOCTURIA 50 0.0041
797 MUSCULOSKELETAL DISORDER 78 0.0041
798 BRONCHOSPASM 58 0.0041
799 CARDIOGENIC SHOCK 58 0.0040
800 ALOPECIA 793 0.0040
801 FACE OEDEMA 68 0.0040
802 MULTIPLE FRACTURES 66 0.0040
803 MUSCULOSKELETAL DISCOMFORT 69 0.0040
804 GASTROINTESTINAL HAEMORRHAGE 335 0.0040
805 DIABETES MELLITUS 305 0.0040
806 OROPHARYNGEAL PAIN 369 0.0040
807 WHITE BLOOD CELL COUNT DECREASED 431 0.0040
808 DIZZINESS 1981 0.0040
809 HOT FLUSH 299 0.0040
810 BLOOD URINE PRESENT 75 0.0039
811 RASH PRURITIC 214 0.0039
812 INTENTIONAL OVERDOSE 253 0.0039
813 POLLAKIURIA 164 0.0039
814 FEELING HOT 241 0.0039
815 OSTEONECROSIS 129 0.0039
816 MOVEMENT DISORDER 126 0.0039
817 ATRIAL FIBRILLATION 382 0.0039
818 APATHY 57 0.0039
819 ELECTROCARDIOGRAM QT PROLONGED 140 0.0039
820 GINGIVAL BLEEDING 53 0.0039
821 ANKYLOSING SPONDYLITIS 51 0.0039
822 UPPER GASTROINTESTINAL HAEMORRHAGE 65 0.0039
823 HEPATOTOXICITY 86 0.0039
824 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 90 0.0039
825 DRUG DISPENSING ERROR 59 0.0039
826 PERICARDIAL EFFUSION 89 0.0038
827 MANIA 63 0.0038
828 PRESYNCOPE 93 0.0038
829 STEVENS-JOHNSON SYNDROME 85 0.0038
830 GASTROENTERITIS VIRAL 69 0.0038
831 MOOD ALTERED 104 0.0038
832 FEMUR FRACTURE 118 0.0038
833 SENSORY DISTURBANCE 61 0.0038
834 DRUG INEFFECTIVE 5006 0.0038
835 APHONIA 53 0.0038
836 HOSPITALISATION 583 0.0038
837 OFF LABEL USE 3311 0.0038
838 FLUID OVERLOAD 55 0.0038
839 NEOPLASM MALIGNANT 252 0.0038
840 PHOTOPHOBIA 71 0.0038
841 HYPOGLYCAEMIA 183 0.0038
842 INFLUENZA LIKE ILLNESS 310 0.0038
843 CARDIAC FAILURE CONGESTIVE 302 0.0038
844 COUGH 1048 0.0037
845 SKIN LESION 102 0.0037
846 CYST 46 0.0037
847 HYPOTHYROIDISM 118 0.0037
848 HAEMATURIA 126 0.0037
849 HAEMATOMA 95 0.0037
850 PRODUCT PRESCRIBING ERROR 87 0.0036
851 TRANSIENT ISCHAEMIC ATTACK 123 0.0036
852 JAUNDICE 98 0.0036
853 ARRHYTHMIA 171 0.0036
854 FEELING ABNORMAL 862 0.0036
855 DRUG PRESCRIBING ERROR 69 0.0036
856 MELAENA 79 0.0036
857 CHROMATURIA 81 0.0036
858 DERMATITIS 75 0.0036
859 ACUTE MYOCARDIAL INFARCTION 105 0.0036
860 PARAESTHESIA 558 0.0035
861 BURNING SENSATION 248 0.0035
862 RESPIRATORY TRACT INFECTION 92 0.0035
863 INTERSTITIAL LUNG DISEASE 170 0.0035
864 BLINDNESS 143 0.0035
865 PSYCHOMOTOR HYPERACTIVITY 58 0.0035
866 MIDDLE INSOMNIA 65 0.0035
867 EPISTAXIS 260 0.0035
868 TINNITUS 159 0.0035
869 LABORATORY TEST ABNORMAL 102 0.0035
870 SYNCOPE 343 0.0034
871 ADVERSE EVENT 315 0.0034
872 ABASIA 84 0.0034
873 SKIN DISCOLOURATION 156 0.0034
874 PREMATURE DELIVERY 54 0.0034
875 CEREBROVASCULAR ACCIDENT 570 0.0034
876 THROAT TIGHTNESS 91 0.0034
877 THIRST 60 0.0034
878 SKIN DISORDER 112 0.0034
879 LIMB DISCOMFORT 103 0.0033
880 LOCAL SWELLING 58 0.0033
881 INTENTIONAL SELF-INJURY 67 0.0033
882 ABNORMAL DREAMS 91 0.0033
883 MUSCLE TIGHTNESS 53 0.0033
884 VERTIGO 199 0.0033
885 NASAL CONGESTION 189 0.0032
886 EPILEPSY 98 0.0032
887 ABDOMINAL PAIN LOWER 81 0.0032
888 SKIN EXFOLIATION 270 0.0032
889 BRAIN FOG 50 0.0032
890 LUNG NEOPLASM MALIGNANT 130 0.0032
891 LUNG INFECTION 49 0.0032
892 CARDIAC FAILURE 253 0.0031
893 THROAT IRRITATION 140 0.0031
894 MYALGIA 530 0.0031
895 EXTRAPYRAMIDAL DISORDER 77 0.0031
896 FRACTURE 58 0.0031
897 NERVOUSNESS 159 0.0030
898 VISION BLURRED 417 0.0030
899 TENDONITIS 47 0.0030
900 DRUG EFFECT INCOMPLETE 110 0.0030
901 DRUG EFFECT DECREASED 163 0.0030
902 LACRIMATION INCREASED 91 0.0030
903 FLATULENCE 170 0.0030
904 CONJUNCTIVITIS 55 0.0030
905 CEREBRAL HAEMORRHAGE 106 0.0030
906 CARDIOVASCULAR DISORDER 75 0.0030
907 DIPLOPIA 76 0.0029
908 RASH MACULO-PAPULAR 65 0.0029
909 BLOOD PRESSURE ABNORMAL 58 0.0029
910 FAECES DISCOLOURED 63 0.0029
911 BONE MARROW FAILURE 59 0.0029
912 TREATMENT NONCOMPLIANCE 157 0.0029
913 MYOCARDIAL INFARCTION 497 0.0028
914 PHOTOSENSITIVITY REACTION 47 0.0028
915 RENAL IMPAIRMENT 238 0.0028
916 PRODUCT ADMINISTRATION ERROR 57 0.0028
917 NEEDLE ISSUE 82 0.0028
918 HAEMORRHAGE 291 0.0028
919 VIRAL INFECTION 91 0.0027
920 LIP SWELLING 90 0.0027
921 EYE SWELLING 100 0.0027
922 ANAPHYLACTIC SHOCK 68 0.0026
923 EYE PAIN 148 0.0026
924 SKIN FISSURES 51 0.0026
925 PRODUCT QUALITY ISSUE 354 0.0026
926 OCULAR HYPERAEMIA 123 0.0026
927 WRONG TECHNIQUE IN DRUG USAGE PROCESS 93 0.0026
928 RASH GENERALISED 66 0.0025
929 ERUCTATION 49 0.0025
930 INJECTION SITE WARMTH 51 0.0025
931 GLAUCOMA 47 0.0024
932 FLUSHING 245 0.0024
933 LACTIC ACIDOSIS 78 0.0024
934 BONE DENSITY DECREASED 75 0.0024
935 DRY EYE 118 0.0024
936 AGEUSIA 58 0.0023
937 PRURITUS GENERALISED 50 0.0023
938 CEREBRAL INFARCTION 56 0.0023
939 DYSGEUSIA 169 0.0023
940 INJECTION SITE MASS 83 0.0022
941 EYE DISORDER 72 0.0022
942 RASH MACULAR 75 0.0021
943 RASH PAPULAR 47 0.0021
944 PRODUCT DOSE OMISSION ISSUE 595 0.0020
945 DIABETIC KETOACIDOSIS 48 0.0020
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 359 0.0020
947 COVID-19 346 0.0020
948 THERAPEUTIC RESPONSE UNEXPECTED 88 0.0020
949 PRODUCT DOSE OMISSION 124 0.0019
950 MULTIPLE SCLEROSIS 90 0.0019
951 PANCREATIC CARCINOMA 54 0.0019
952 VISUAL ACUITY REDUCED 62 0.0019
953 HEPATIC FUNCTION ABNORMAL 69 0.0018
954 BLOOD GLUCOSE DECREASED 88 0.0018
955 PAIN OF SKIN 48 0.0018
956 DRUG EXPOSURE DURING PREGNANCY 57 0.0017
957 DRY SKIN 222 0.0017
958 PRODUCT DOSE OMISSION IN ERROR 47 0.0017
959 THERAPEUTIC RESPONSE SHORTENED 55 0.0017
960 INTENTIONAL DOSE OMISSION 46 0.0016
961 DRUG ADMINISTRATION ERROR 49 0.0016
962 INCORRECT DOSE ADMINISTERED 361 0.0016
963 UNDERDOSE 114 0.0016
964 INJECTION SITE REACTION 105 0.0015
965 ECZEMA 78 0.0015
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 50 0.0015
967 THERAPY INTERRUPTED 103 0.0014
968 BLOOD GLUCOSE INCREASED 267 0.0014
969 MULTIPLE SCLEROSIS RELAPSE 97 0.0014
970 THERAPY CESSATION 70 0.0014
971 PRODUCT SUBSTITUTION ISSUE 78 0.0014
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 95 0.0013
973 DRUG DOSE OMISSION 216 0.0013
974 ABORTION SPONTANEOUS 49 0.0012
975 DISEASE RECURRENCE 58 0.0012
976 DEVICE MALFUNCTION 83 0.0012
977 EYE IRRITATION 66 0.0011
978 ACNE 85 0.0011
979 INJECTION SITE ERYTHEMA 137 0.0011
980 PROSTATE CANCER 86 0.0011
981 INJECTION SITE BRUISING 84 0.0011
982 SKIN IRRITATION 48 0.0010
983 INJECTION SITE PAIN 299 0.0010
984 INJECTION SITE PRURITUS 62 0.0009
985 DEVICE ISSUE 81 0.0009
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 173 0.0009
987 SKIN BURNING SENSATION 60 0.0008
988 INJECTION SITE HAEMORRHAGE 65 0.0008
989 BREAST CANCER 73 0.0008
990 INJECTION SITE SWELLING 52 0.0007
991 ACCIDENTAL EXPOSURE TO PRODUCT 58 0.0006
992 NO ADVERSE EVENT 78 0.0004